Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma

Clinica Chimica Acta

Volumn 347, Issue 1-2, 2004, Pages 129-138

  Cillo, Umberto ^a   Navaglia, Filippo ^a   Vitale, Alessandro ^a   Molari, Alfiero ^a   Basso, Daniela ^a   Bassanello, Marco ^a   Brolese, Alberto ^a   Zanus, Giacomo ^a   Montin, Umberto ^a   D'Amico, Francesco ^a   Ciarleglio, Francesco Antonio ^a   Carraro, Amedeo ^a   Bridda, Alessio ^a   Burra, Patrizia ^a   Carraro, Paolo ^a   Plebani, Mario ^a   D'Amico, Davide Francesco ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

AFP; alanine aminotransferase; alkaline phosphatase; ALP; alpha fetoprotein; ALT; aspartate aminotransferase; AST; Cholestatic index; gamma glutamyl transferase; GGT; Grading; HCC; hepatocellular carcinoma; liver transplantation; Nodule size; OLT; Vascular invasion

Indexed keywords

ALPHA FETOPROTEIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; METASTASIS; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; COLONIC NEOPLASMS; DNA PRIMERS; DNA, NEOPLASM; ELECTROPHORESIS, AGAR GEL; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 4143121181     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.04.032     Document Type: Article

References (35)

1. Befeler A.S., Di Bisceglie A.M. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology. 122:2002;1609-1619
2. ElSerag H.B., Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 340:1999;745-750
3. Bruix J., Llovet J.M. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 35:2002;519-524
4. Ikeda K., Saitoh S., Tsubota A., et al. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer. 71:1993;19-25
5. Ercolani G., Grazi G., Ravaioli M., et al. Liver resection for hepatocellular carcinoma on cirrhosis. Univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann. Surg. 237:2003;536-543
6. Hermanek P., Sobin L.H., Wittekind C. How to improve the present TNM staging system. Cancer. 86:1999;189-191
7. Matsumura M., Niwa Y., Kato N., et al. Detection of α-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology. 20:1994;1418-1425
8. Funaki N.O., Tanaka J., Seto S.I., et al. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver. Hepatology. 25:1997;564-568
9. Louha M., Poussin K., Ganne N., et al. Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer. Hepatology. 26:1997;998-1005
10. Matsumura M., Shiratori Y., Niwa Y., et al. Presence of α-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma. J. Hepatol. 31:1999;332-339
11. Minata M., Nishida N., Komeda T., et al. Postoperative detection of α-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 16:2001;445-451
12. Ijichi M., Takayama T., Matsumura M., et al. Presence of α-fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study. Hepatology. 35:2002;853-860
13. Lemoine A., Le Bricon T., Salvucci M., et al. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery. Ann. Surg. 226:1997;43-50
14. Witzigmann H., Geissler F., Benedix F., et al. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma. Surgery. 131:2002;34-43
15. Sobin L.H., Wittekind C.H. UICC (1997) TNM classification of malignant tumors. 5th ed.:1997;Wiley, New York
16. Liefers G.J., Cleton-Jansen A.M., van de Velde C.J., et al. Micrometastases and survival in stage II colorectal cancer. N. Engl. J. Med. 339:1998;223-228
17. Peck K., Sher Y.P., Shih J.Y., et al. Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients. Cancer Res. 58:1998;2761-2765
18. Eschwege P., Dumas F., Blanchet P., et al. Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet. 346:1995;1528-1530
19. Chevret S., Trinchet J.C., Mathieu D., Rached A.A., Beaugrand M., Chastang C. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. J. Hepatol. 31:1999;133-141
20. Leung T.W., Tang A.M., Zee B., et al. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system. Cancer. 94:2002;1760-1769
21. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med. 334:1996;693-699
22. Kirimlioglu H., Dvorchick I., Ruppert K., et al. Hepatocellular carcinomas in native livers from patients with orthotopic liver transplantation: biologic and therapeutic implications. Hepatology. 34:2001;502-510
23. De Carlis L., Giacomoni A., Lauterio A., et al. Liver transplantation for hepatocellular cancer: should the current indication criteria be changed. Transpl. Int. 16:2003;115-122
24. Marsh J.W., Dvorichik I., Subotin M., et al. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology. 26:1997;444-450
25. Marsh J.W., Dvorchik I., Bonham C.A., Iwatsuki S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer. 88:2000;538-543
26. Hemming A.W., Cattral M.S., Reed A.I., et al. Liver transplantation for hepatocellular carcinoma. Ann. Surg. 233:2001;652-659
27. Lauwers G.Y., Terris B., Balis K.P., et al. Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic index. Am. J. Surg. Pathol. 26:2002;25-34
28. Yamanaka J., Yamanaka N., Nakasho K., et al. Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection. J. Gastroenterol. Hepatol. 15:2000;1192-1198
29. Jonas S., Bechstein W.O., Steinmuller T., et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology. 33:2001;1080-1086
30. Vauthey J.N., Lauwers G.Y., Esnaola N.F., et al. Simplified staging for hepatocellular carcinoma. J. Clin. Oncol. 20:2002;1527-1536
31. Park N.H., Chung Y.H., Youn K.H., et al. Close correlation of p53 mutation to microvascular invasion in hepatocellular carcinoma. J. Clin. Gastroenterol. 33:2001;397-401
32. Esnaola N.F., Lauwers G.Y., Mirza N.Q., et al. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J. Gastrointest. Surg. 6:2002;224-232
33. Cillo U., Vitale A., Bassanello M., et al. Liver transplantation for the treatment of moderately- or well-differentiated hepatocellular carcinoma. Ann Surg. 239:2004;150-159
34. Klintmalm G.B. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of the tumor characteristics on outcome. Ann. Surg. 228:1998;479-490
35. Tamura S., Kato T., Berho M., et al. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch. Surg. 136:2001;25-30